Healthy Returns: J&J, Merck and Bristol Myers Squibb in the hot seat
J&J, Merck and Bristol Myers Squibb face a pivotal few weeks ahead. Meanwhile, Apple will reportedly explore health applications for the Vision Pro headset.
Stay updated with breaking news from Johnson Amp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
J&J, Merck and Bristol Myers Squibb face a pivotal few weeks ahead. Meanwhile, Apple will reportedly explore health applications for the Vision Pro headset.
The Delhi High Court has upheld the constitutional validity of anti-profiteering provisions under the Goods and Services Tax (GST) framework. Over 50 top companies, including Hindustan Unilever, Abbott, Johnson & Johnson, and Nestle, had challenged these measures. The court stated that the provisions are a consumer welfare measure and do not violate constitutional provisions.
Here are the most important news items that investors need to start their trading day.
While the S&P 500 rose 24% in 2023, the S&P 500 Pharmaceuticals industry index slipped 2.2%. Lilly and Novo Nordisk were the exceptions in a slumping...
Fast-approaching patent expirations will take a bite out of revenues and put the industry's top players in the hot seat over the next few years.